Reversible Human TGF-β Signal Shifting Between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions

Overview

Journal J Clin Med

Specialty General Medicine

Date 2016 Jan 16

PMID 26771649

Citations 19

Authors

Katsunori Yoshida

Miki Murata

Takashi Yamaguchi

Koichi Matsuzaki

Kazuichi Okazaki

Affiliations

Soon will be listed here.

Abstract

Epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) are observed during both physiological liver wound healing and the pathological fibrotic/carcinogenic (fibro-carcinogenetic) process. TGF-β and pro-inflammatory cytokine are considered to be the major factors accelerating liver fibrosis and promoting liver carcinogenesis. Smads, consisting of intermediate linker regions connecting Mad homology domains, act as the intracellular mediators of the TGF-β signal transduction pathway. As the TGF-β receptors, c-Jun N-terminal kinase and cyclin-dependent kinase, differentially phosphorylate Smad2/3, we have generated numerous antibodies against linker (L) and C-terminal (C) phosphorylation sites in Smad2/3 and identified four types of phosphorylated forms: cytostatic COOH-terminally-phosphorylated Smad3 (pSmad3C), mitogenic pSmad3L (Ser-213) signaling, fibrogenic pSmad2L (Ser-245/250/255)/C signaling and migratory pSmad2/3L (Thr-220/179)/C signaling. After acute liver injury, TGF-β upregulates pSmad3C signaling and terminates pSmad3L (Ser-213)-mediated hepatocyte proliferation. TGF-β and pro-inflammatory cytokines cooperatively enhance collagen synthesis by upregulating pSmad2L (Thr-220)/C and pSmad3L (Thr-179)/C pathways in activated hepatic stellate cells. During chronic liver injuries, hepatocytes persistently affected by TGF-β and pro-inflammatory cytokines eventually become pre-neoplastic hepatocytes. Both myofibroblasts and pre-neoplastic hepatocyte exhibit the same carcinogenic (mitogenic) pSmad3L (Ser-213) and fibrogenic pSmad2L (Ser-245/250/255)/C signaling, with acquisition of fibro-carcinogenic properties and increasing risk of hepatocellular carcinoma (HCC). Firstly, we review phospho-Smad-isoform signalings in epithelial and mesenchymal cells in physiological and pathological conditions and then consider Smad linker phosphorylation as a potential target for pathological EMT during human fibro-carcinogenesis, because human Smad phospho-isoform signals can reverse from fibro-carcinogenesis to tumor-suppression in a process of MET after therapy.

Citing Articles

TRIM55 restricts the progression of hepatocellular carcinoma through ubiquitin-proteasome-mediated degradation of NF90.

Luo C, Lu Y, Fang Q, Lu J, Zhan P, Xi W Cell Death Discov. 2024; 10(1):441.

PMID: 39420007 PMC: 11487063. DOI: 10.1038/s41420-024-02212-y.

TGF-β downstream of Smad3 and MAPK signaling antagonistically regulate the viability and partial epithelial-mesenchymal transition of liver progenitor cells.

Sun Y, Wu Y, Li G, Liang H, Yong T, Li Z Aging (Albany NY). 2024; 16(7):6588-6612.

PMID: 38604156 PMC: 11042936. DOI: 10.18632/aging.205725.

FXR1 promotes proliferation, invasion and migration of hepatocellular carcinoma and .

Zhao K, Gao J, Shi J, Shi C, Pang C, Li J Oncol Lett. 2022; 25(1):22.

PMID: 36466996 PMC: 9713760. DOI: 10.3892/ol.2022.13608.

Adherens junctions organize size-selective proteolytic hotspots critical for Notch signalling.

Kwak M, Southard K, Kim W, Lin A, Kim N, Gopalappa R Nat Cell Biol. 2022; 24(12):1739-1753.

PMID: 36456828 PMC: 10665132. DOI: 10.1038/s41556-022-01031-6.

Effects of on tumor microenvironment and immunotherapy responses.

Deng R, Zheng H, Cai H, Li M, Shi Y, Ding S Front Immunol. 2022; 13:923477.

PMID: 35967444 PMC: 9371381. DOI: 10.3389/fimmu.2022.923477.

References

Galuppo R, Maynard E, Shah M, Daily M, Chen C, Spear B . Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS/RAF/MAPK and WNT/β-catenin pathways. Anticancer Res. 2014; 34(4):1709-13. PMC: 5733784. View

Pinzani M, Gesualdo L, Sabbah G, Abboud H . Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest. 1989; 84(6):1786-93. PMC: 304056. DOI: 10.1172/JCI114363. View

Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, Schuster N . The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol. 2008; 10(10):1199-207. DOI: 10.1038/ncb1780. View

Deng Y, Yoshida K, Jin Q, Murata M, Yamaguchi T, Tsuneyama K . Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection. Clin Exp Immunol. 2013; 176(1):102-11. PMC: 3958159. DOI: 10.1111/cei.12259. View

Miyoshi H, Ajima R, Luo C, Yamaguchi T, Stappenbeck T . Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. Science. 2012; 338(6103):108-13. PMC: 3706630. DOI: 10.1126/science.1223821. View

Kang Y, He W, Tulley S, Gupta G, Serganova I, Chen C . Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc Natl Acad Sci U S A. 2005; 102(39):13909-14. PMC: 1236573. DOI: 10.1073/pnas.0506517102. View

Fernando J, Malfettone A, Cepeda E, Vilarrasa-Blasi R, Bertran E, Raimondi G . A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells. Int J Cancer. 2014; 136(4):E161-72. DOI: 10.1002/ijc.29097. View

Greenburg G, Hay E . Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol. 1982; 95(1):333-9. PMC: 2112361. DOI: 10.1083/jcb.95.1.333. View

Larue L, Bellacosa A . Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene. 2005; 24(50):7443-54. DOI: 10.1038/sj.onc.1209091. View

10.

Nagata H, Hatano E, Tada M, Murata M, Kitamura K, Asechi H . Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma. Hepatology. 2009; 49(6):1944-53. DOI: 10.1002/hep.22860. View

11.

Friedman S . Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol. 2005; 1(2):98-105. DOI: 10.1038/ncpgasthep0055. View

12.

Zavadil J, Bottinger E . TGF-beta and epithelial-to-mesenchymal transitions. Oncogene. 2005; 24(37):5764-74. DOI: 10.1038/sj.onc.1208927. View

13.

Weng H, Liu Y, Chen J, Huang T, Xu L, Godoy P . The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis. Hepatology. 2009; 50(1):230-43. DOI: 10.1002/hep.22934. View

14.

Shi Y, Massague J . Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003; 113(6):685-700. DOI: 10.1016/s0092-8674(03)00432-x. View

15.

Date M, Matsuzaki K, Matsushita M, Tahashi Y, Furukawa F, Inoue K . Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury. Gut. 2000; 46(5):719-24. PMC: 1727924. DOI: 10.1136/gut.46.5.719. View

16.

Baum B, Settleman J, Quinlan M . Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol. 2008; 19(3):294-308. DOI: 10.1016/j.semcdb.2008.02.001. View

17.

Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S . Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Hepatology. 2009; 49(4):1203-17. DOI: 10.1002/hep.22765. View

18.

Marra F . Chemokines in liver inflammation and fibrosis. Front Biosci. 2002; 7:d1899-914. DOI: 10.2741/A887. View

19.

Bellam N, Pasche B . Tgf-beta signaling alterations and colon cancer. Cancer Treat Res. 2010; 155:85-103. DOI: 10.1007/978-1-4419-6033-7_5. View

20.

Xu J, Lamouille S, Derynck R . TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009; 19(2):156-72. PMC: 4720263. DOI: 10.1038/cr.2009.5. View